ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 142,01
0,82%
Dow Jones
38 884,26
0,00%
DAX
18 488,14
0,27%
Brent Oil
82,185
-0,82%
Bitcoin
62 332,51
0,00%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Hemispherx Biopharma Inc New (HEB)

  7. Hemispherx Biopharma Inc New (HEB) Actualités

HEB

Hemispherx Biopharma (HEB)

Hemispherx Biopharma Inc New
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:HEB
DateHeureSourceTitreSymboleSociété
05/06/202023h00Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HEBHemispherx Biopharma Inc New
14/05/202014h21Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:HEBHemispherx Biopharma Inc New
30/03/202023h24Edgar (US Regulatory)Annual Report (10-k)AMEX:HEBHemispherx Biopharma Inc New
10/03/202022h20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:HEBHemispherx Biopharma Inc New
14/02/202023h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:HEBHemispherx Biopharma Inc New
31/01/202019h46Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:HEBHemispherx Biopharma Inc New
02/01/202017h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HEBHemispherx Biopharma Inc New
14/11/201922h35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HEBHemispherx Biopharma Inc New
26/09/201923h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)AMEX:HEBHemispherx Biopharma Inc New
26/09/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:HEBHemispherx Biopharma Inc New
25/09/201912h02Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:HEBHemispherx Biopharma Inc New
20/09/201917h37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:HEBHemispherx Biopharma Inc New
06/09/201923h02Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:HEBHemispherx Biopharma Inc New
23/08/201912h50GlobeNewswire Inc.Hemispherx Biopharma, Inc. Changes Name to AIM ImmunoTech Inc. Reflecting Ampligen’s® Immuno Modulation Progress in Ongoin...AMEX:HEBHemispherx Biopharma Inc New
20/08/201922h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:HEBHemispherx Biopharma Inc New
15/08/201912h45GlobeNewswire Inc.Hemispherx Issues 2019 Second Quarter Report Citing Strong Steady Progress in Cancer Clinical TrialsAMEX:HEBHemispherx Biopharma Inc New
08/08/201912h50GlobeNewswire Inc.Hemispherx Reports Positive Safety and Survival Data in Phase 1 Stage 4 Ovarian Cancer Clinical Study Using Ampligen®AMEX:HEBHemispherx Biopharma Inc New
02/08/201912h45GlobeNewswire Inc.Hemispherx Secures Corrections from Two Stock News Organizations Related to Their Inaccurate Reporting of an Equity Distribut...AMEX:HEBHemispherx Biopharma Inc New
28/06/201922h06Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:HEBHemispherx Biopharma Inc New
28/06/201913h00GlobeNewswire Inc.Hemispherx Biopharma CFO Adam Pascale Announces RetirementAMEX:HEBHemispherx Biopharma Inc New
25/06/201918h18Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:HEBHemispherx Biopharma Inc New
18/06/201922h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:HEBHemispherx Biopharma Inc New
17/06/201914h30GlobeNewswire Inc.Hemispherx Biopharma Issues Clinical Update for Ampligen Immuno-oncology ProgramAMEX:HEBHemispherx Biopharma Inc New
12/06/201921h31GlobeNewswire Inc.Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combinat...AMEX:HEBHemispherx Biopharma Inc New
31/05/201916h16GlobeNewswire Inc.Hemispherx Biopharma Stockholders Approve Reverse Stock SplitAMEX:HEBHemispherx Biopharma Inc New
16/05/201914h30GlobeNewswire Inc.Hemispherx Reports 2019 First Quarter Financial ResultsAMEX:HEBHemispherx Biopharma Inc New
13/05/201918h22GlobeNewswire Inc.Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center Edges Closer for Hemispherx BiopharmaAMEX:HEBHemispherx Biopharma Inc New
13/05/201914h30GlobeNewswire Inc.Hemispherx Announces Progress Toward Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer CenterAMEX:HEBHemispherx Biopharma Inc New
08/05/201914h30GlobeNewswire Inc.Hemispherx Biopharma's CEO to Attend BioFlorida Inc.’s 2019 Celebration of BiotechnologyAMEX:HEBHemispherx Biopharma Inc New
06/05/201914h30GlobeNewswire Inc.Hemispherx Links Stanford’s ME/CFS Diagnostic to a Potential Path Forward for Ampligen CommercializationAMEX:HEBHemispherx Biopharma Inc New
 Showing the most relevant articles for your search:AMEX:HEB

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
EU
AI
Air Liquide
EU
PX4
SBF 120
EU
SGO
Cie de SaintGobain
EU
AF
Air FranceKLM
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
EU
CAP
Capgemini
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés